 NCI-H1915(ICGE-NCI-H1915,IC-82484)
  NCI-H1915(ICGE-NCI-H1915,IC-82484)

Overview
        | Permits and Restrictions | |
|---|---|
| Organism | Homo sapiens, human | 
| Tissue | lung | 
| Cell Type | large cell | 
| Product Format | frozen | 
| Culture Properties | adherent | 
| Biosafety Level | 1 Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. | 
| Disease | stage 4, poorly differentiated carcinoma; non-small cell lung cancer | 
| Age | 61 years | 
| Gender | female | 
| Ethnicity | Caucasian | 
| Storage Conditions | liquid nitrogen vapor phase | 
Properties
        | Derivation | 
					The line was established in April 1988.
				 
					The line was developed from a brain metastasis (probably from a primary lung carcinoma).
				 | 
|---|---|
| Clinical Data | 
					The tissue donor was a non-smoker.
				 | 
Background
        | Complete Growth Medium | The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%. | 
|---|---|
| Subculturing | Volumes used in this protocol are for 75 cm2 flask; proportionally reduce or increase amount of dissociation medium for culture vessels of other sizes. 
 
					Subcultivation Ratio: 1:3 to 1:4 Note: For more information on enzymatic dissociation and subculturing of cell lines consult Chapter 10 in Culture of Animal Cells, a Manual of Basic Technique by R. Ian Freshney, 3rd edition, published by Alan R. Liss, N.Y., 1994. | 
| Cryopreservation | 
					Culture medium, 95%; DMSO, 5%. Cell culture tested DMSO is available as ATCC Catalog No. 4-X.
				 | 








